Literature DB >> 27060029

Next-Generation Sequencing of the HLA locus: Methods and impacts on HLA typing, population genetics and disease association studies.

Raphael Carapito1, Mirjana Radosavljevic2, Seiamak Bahram3.   

Abstract

The human Major Histocompatibility Complex, known as the "Human Leukocyte Antigen (HLA)", could be defined as a "super locus" (historically called "supergene") governing the adaptive immune system in vertebrates. It also harbors genes involved in innate immunity. HLA is the most gene-dense, polymorphic and disease-associated region of the human genome. It is of critical medical relevance given its involvement in the fate of the transplanted organs/tissues and its association with more than 100 diseases. However, despite these important roles, comprehensive sequence analysis of the 4 megabase HLA locus has been limited due to technological challenges. Thanks to recent improvements in Next-Generation Sequencing (NGS) technologies however, one is now able to handle the peculiarities of the MHC notably the tight linkage disequilibrium between genes as well as their high degree of polymorphism (and hence heterozygosity). Increased read lengths, throughput, accuracy, as well as development of new bioinformatics tools now enable to efficiently generate complete and accurate full-length HLA haplotypes without phase ambiguities. The present report reviews current NGS approaches to capture, sequence and analyze HLA genes and loci. The impact of these new methodologies on various applications including HLA typing, population genetics and disease association studies are discussed.
Copyright © 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HLA; HLA typing; HLA-disease association; NGS; Population genetics

Mesh:

Substances:

Year:  2016        PMID: 27060029     DOI: 10.1016/j.humimm.2016.04.002

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  27 in total

1.  A New Fast Phasing Method Based On Haplotype Subtraction.

Authors:  Evelina Mocci; Marija Debeljak; Alison P Klein; James R Eshleman
Journal:  J Mol Diagn       Date:  2019-03-11       Impact factor: 5.568

2.  High-resolution characterization of allelic and haplotypic HLA frequency distribution in a Spanish population using high-throughput next-generation sequencing.

Authors:  Gonzalo Montero-Martín; Kalyan C Mallempati; Sridevi Gangavarapu; Francisco Sánchez-Gordo; Maria J Herrero-Mata; Antonio Balas; Jose L Vicario; Florentino Sánchez-García; Maria F González-Escribano; Manuel Muro; Maria R Moya-Quiles; Rafael González-Fernández; Javier G Ocejo-Vinyals; Luis Marín; Lisa E Creary; Kazutoyo Osoegawa; Tamara Vayntrub; Jose L Caro-Oleas; Carlos Vilches; Dolores Planelles; Marcelo A Fernández-Viña
Journal:  Hum Immunol       Date:  2019-02-11       Impact factor: 2.850

3.  A Rapid Allele-Specific Assay for HLA-A*32:01 to Identify Patients at Risk for Vancomycin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms.

Authors:  Francois X Rwandamuriye; Abha Chopra; Katherine C Konvinse; Linda Choo; Jason A Trubiano; Christian M Shaffer; Mark Watson; Simon A Mallal; Elizabeth J Phillips
Journal:  J Mol Diagn       Date:  2019-05-31       Impact factor: 5.568

Review 4.  Strategies for the measurements of expression levels and half-lives of HLA class I allotypes.

Authors:  Malini Raghavan; Brogan Yarzabek; Anita J Zaitouna; Sujatha Krishnakumar; Daniel S Ramon
Journal:  Hum Immunol       Date:  2019-02-05       Impact factor: 2.850

Review 5.  An Illumina approach to MHC typing of Atlantic salmon.

Authors:  Arvind Y M Sundaram; Åse Helen Garseth; Giuseppe Maccari; Unni Grimholt
Journal:  Immunogenetics       Date:  2019-11-12       Impact factor: 2.846

6.  Complete nucleotide sequence characterization of DRB5 alleles reveals a homogeneous allele group that is distinct from other DRB genes.

Authors:  Konstantinos Barsakis; Farbod Babrzadeh; Anjo Chi; Kalyan Mallempati; William Pickle; Michael Mindrinos; Marcelo A Fernández-Viña
Journal:  Hum Immunol       Date:  2019-04-05       Impact factor: 2.850

7.  Screening HLA to Prevent Severe Drug Reactions-A Devil's Advocate Perspective.

Authors:  Sherrie J Divito
Journal:  JAMA Dermatol       Date:  2019-06-01       Impact factor: 10.282

Review 8.  Exploring the ancestry and admixture of Mexican Oaxaca Mestizos from Southeast Mexico using next-generation sequencing of 11 HLA loci.

Authors:  B A González-Quezada; L E Creary; A J Munguia-Saldaña; H Flores-Aguilar; M A Fernández-Viña; C Gorodezky
Journal:  Hum Immunol       Date:  2019-01-29       Impact factor: 2.850

Review 9.  Next-Generation Sequencing Technologies in Blood Group Typing.

Authors:  Daniel Fürst; Chrysanthi Tsamadou; Christine Neuchel; Hubert Schrezenmeier; Joannis Mytilineos; Christof Weinstock
Journal:  Transfus Med Hemother       Date:  2019-12-11       Impact factor: 3.747

Review 10.  MinION: A Novel Tool for Predicting Drug Hypersensitivity?

Authors:  Eng Wee Chua; Pei Yuen Ng
Journal:  Front Pharmacol       Date:  2016-06-14       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.